Diferencia entre revisiones de «Chromium toxicity»

Línea 40: Línea 40:
| align="center" style="background:#f0f0f0;"|'''Elimination'''
| align="center" style="background:#f0f0f0;"|'''Elimination'''
|-
|-
| Cr<sup>3+</sup>||Rarely develops toxicity||Limited oral absorption with 98% recovered in feces||Cr6+ is rapidly converted to Cr3+ in the blood||Urinary excretion
| Cr<sup>3+</sup>||
*Rarely develops toxicity
||
*Limited oral absorption with 98% recovered in feces
||
*Cr6+ is rapidly converted to Cr3+ in the blood
||
*Urinary excretion
|-
|-
| Cr<sup>6+</sup>||Main cause of toxicity *Oxidative agent producing oxidative DNA damage||Modestly absorbed **10% orally **50-85% inhalational||||50% total body burden is localized to the kidney and liver *With additional stores in bone marrow, lymph nodes, spleen, and testes
| Cr<sup>6+</sup>||
*Main cause of toxicity  
*Oxidative agent producing oxidative DNA damage
||
*Modestly absorbed  
**10% orally  
**50-85% inhalational
||||
*50% total body burden is localized to the kidney and liver  
**With additional stores in bone marrow, lymph nodes, spleen, and testes
|}
|}



Revisión del 03:03 10 ago 2018

Background

  • Blue white metal
  • Essential in glucose and fat metabolism
  • The predominant forms are trivalent (Cr3+) and hexavalent (Cr6+)
  • Cr6+ is a carcinogen
  • Uses
    • Chrome platting
    • Component of making stainless steel
    • Used to make cement
    • Welding
    • Joint arthroplasty
    • Coronary artery stents
    • Tanned leather products

Toxicokinetics

  • Absorption
    • Cr3+
      • Limited oral absorption with 98% recovered in feces
    • Cr6+
      • Modestly absorbed
        • 10% orally
        • 50-85% inhalational
  • Distribution
    • Cr6+ is rapidly converted to Cr3+ in the blood
    • 50% total body burden is localized to the kidney and liver
      • With additional stores in bone marrow, lymph nodes, spleen, and testes
  • Elimination
    • Urinary excretion of Cr3+ form
  • Cr6+
    • Oxidative agent producing oxidative DNA damage
    • Main cause of toxicity
  • Cr3+
    • Rarely develops toxicity
Form Toxicity Absorption Distribution Elimination
Cr3+
  • Rarely develops toxicity
  • Limited oral absorption with 98% recovered in feces
  • Cr6+ is rapidly converted to Cr3+ in the blood
  • Urinary excretion
Cr6+
  • Main cause of toxicity
  • Oxidative agent producing oxidative DNA damage
  • Modestly absorbed
    • 10% orally
    • 50-85% inhalational
  • 50% total body burden is localized to the kidney and liver
    • With additional stores in bone marrow, lymph nodes, spleen, and testes

Clinical Features

Differential Diagnosis

Heavy metal toxicity

Evaluation

  • BMP
  • LFTs
  • CBC
  • CPK
  • EKG
  • If toxicity present add coagulation factors
  • Chromium levels
    • Whole blood: 20-30 μg/L (380-580 nmol/L)
    • Serum: 0.05-2.86 μg/L (1-56 nmol/L)
    • Urine: < 1μg/g creatinine (<19.2 nmol/g creatinine)
      • Can reflect acute absorption of chromium over the past 1-2 days, however wide variation in metabolism and total body burden
    • Baseline levels have varied over the past 50 years by 5000-fold, additionally it is difficult to establish standard reference range, use caution when interpreting these levels
    • Phlebotomy needles and blood containers for storage contain chromium

Management

  • Decontamination
    • Activated charcoal not indicated
    • Consider NG lavage if Cr6+ ingestion and presenting within 1-2 hours without signs of vomiting
    • Consider oral N-acetylcysteine
      • Shown to increases renal elimination of chromium in rats
  • Supportive care
  • Chelation
    • Not effective in reducing chromium levels
  • Dialysis
    • Not effective in those with normal renal function
    • Consider in those on chronic dialysis

Disposition

  • Acute toxicity likely requires intensive care unit
  • Consult Toxicology or Poison Control Center

References

Bird, S. Chromium. In: Goldfrank's Toxicologic Emergencies. 9th Ed. New York: McGraw-Hill; 2011: 1243-1247